WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Iovance Biotherapeutics earnings were -$391.0M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest IOVA earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$71.9M, down 21.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IOVA reported annual earnings of -$391.0M, with 5.1% growth.

IOVA earnings history

Current Revenue
$263.5M
Current Earnings
-$391.0M
Current Profit Margin
-148.4%

IOVA Return on Equity

Current Company
-54.5%
Current Industry
-2.5%
Current Market
31.1%
IOVA's Return on Equity (-54.5%)... subscribe to Premium to read more.
High Return on Equity Performance

IOVA Return on Assets

Current Company
-42.4%
Current Industry
-3.5%
IOVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IOVA announces earnings.

IOVA Return on Capital Employed

Current Company
-50.73%
Current Industry
3.1%
IOVA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IOVA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IOVA-$345.73M-$390.98MN/A-$1.09
PVLA-$27.96M-$35.07MN/A-$1.62
ARDX-$35.52M-$61.60MN/A-$0.26
RAPT-$102.44M-$105.64MN/A-$11.64
NTLA-$396.77M-$412.69MN/A-$3.81
View Top Biotech Stocks

Iovance Biotherapeutics Earnings Reports & History FAQ

What were Iovance Biotherapeutics's earnings last quarter?

On IOVA's earnings call on Invalid Date, Iovance Biotherapeutics (NASDAQ: IOVA) reported Q4 2025 earnings per share (EPS) of -$0.15, up 40% year over year. Total IOVA earnings for the quarter were -$71.90 million. In the same quarter last year, Iovance Biotherapeutics's earnings per share (EPS) was -$0.25.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.

Is Iovance Biotherapeutics profitable or losing money?

As of the last Iovance Biotherapeutics earnings report, Iovance Biotherapeutics is currently losing money. Iovance Biotherapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$390.98 million, a 5.05% increase year over year.

What was IOVA's earnings growth in the past year?

As of Iovance Biotherapeutics's earnings date in Invalid Date, Iovance Biotherapeutics's earnings has grown year over year. IOVA earnings in the past year totalled -$390.98 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.